Abstract
Efficient expansion of hematopoietic progenitor cells requires, at least, the simultaneous stimulation of the receptors c-kit and gp130. While c-kit is activated by SCF; gp130, in cells which do not express sufficient amounts of IL-6R, can be activated by the complex of soluble IL-6R (slL-6R) and IL-6. The therapeutic use of IL-6/sIL-6R, however, has been hampered by the high concentrations of the sIL-6R protein required. We have designed a fusion protein of sIL-6R and IL-6, linked by a flexible peptide chain, that was expressed to high levels. On gp130 expressing cells the fusion protein turned out to be fully active at 100 to 1,000-fold lower concentration than the combination of unlinked IL-6 and IL-6R. The fusion protein was used to effectively expand human hematopoietic progenitor cells ex vivo in a dose dependent fashion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mackiewicz, A., Koj, A., and Sehgal, P.B. . 1995. Interleukin-6-Type Cytokines. Proc. N. Y. Acad. Sci 762: 1–522.
Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., and Kishimoto, T. 1988. Cloning and expression of the human interleukin-6 (BSF-2/IFN β2) receptor. Science 241: 825–828.
Davis, S., Aldrich, T.H., Valenzuela, D.M., Wong, V., Furth, M.E., Squinto, S.P., Yancopoulous, G.D., 1991. Receptor for Ciliary Neurotrophic Factor. Science 253: 59–63.
Hilton, D.J., Hilton, A.A., Raicevic, A., Rakar, S., Harrison-Smith, M., Gough, N.M., Begley, C.G., Metcalf, D., Nicola, N.A., and Willson, T.A. 1994. Cloning of a murine IL-11 receptor α-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 13: 4765–4775.
Sui, X., Tsuji, K., Tanaka, R., Tajima, S., Muraoka, K., Ebihara, Y., Ikebuchi, K., Yasukawa, K., Taga, T., Kishimoto, T. and Nakahata, T. 1995. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Proc. Natl. Acad. Sci. USA 92: 2859–2863.
Kishimoto, T., Taga, T., and Akira, S. 1994. Cytokine signal transduction. Cell 76: 253–262.
Rose-John, S. and Heinrich, P.C. 1994. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300: 281–290.
Hirota, H., Kiyama, H., Kishimoto, T., and Taga, T., 1996. Accelerated Nerve Regeneration in Mice by upregulated expression of Interleukin (IL) 6 and IL-6 Receptor. J. Exp Med 183: 2627–2634.
Rose-John, S., Schooltink, H., Lenz, D., Hipp, E., Dufhues, G., Schmitz, H., Schiel, X., Hirano, T., Kishimoto, T., and Heinrich, P.C. 1990. Studies on the structure and regulation of the human hepatic interleukin-6-recep-tor. Eur. J. Biochem. 190: 79–83.
Wells, J.A. Binding in the growth hormone receptor complex. 1996. Proc. Natl. Acad. Sci. USA 93: 1–6.
Toniatti, C., Cabibbo, A., Sporeno, E., Salvati, A.L., Cerretani, M., Serafini, S., Lahm, A., Cortese, R., and Ciliberto, G. 1996. EMBO J. 15: 2726–2737.
Grötzinger, J., Kurapkat, G., Wollmer, A., Kalai, M., and Rose-John, S. 1996. The family of the IL-6-type cytokines: Specificity and Promiscuity of the Receptor Complexes. Proteins, in press.
De Vos, A.M., Ultsch, M., and Kossiakoff, A.A. 1992. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255: 306–312.
Bird, R.E., Hardman, K.D., Jacobson, J.W., Johnson, S., Kaufman, B.M., Lee, S.M., Lee, T., Pope, S.H., Riordan, G.S. and Whitlow, M. 1988. Single-chain antigen-binding proteins. Science 423: 423–426.
Huston, J.S., Levinson, D., Mudgett-Hunter, M., Tai, M.S., Novotny, J., Margolies, M.N., Ridge, R.J., Bruccoleri, R.E., Haber, E., Crea, R. and Oppermann, H. 1988. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 85: 5879–5883.
Yawata, H., Yasukawa, K., Natsuka, S., Murakami, M., Yamasaki, K., Hibi, M., Taga, T., and Kishimoto, T. 1993. Structure-function analysis of the human IL-6 receptor: dissociation of amino acid residues required for IL-6 binding and for IL-6 signal transduction through gp 130. EMBO J. 12: 1705–1712.
Yasukawa, K., Saito, T., Fukunaga, T., Sekimori, Y., Koishihara, Y., Fukui, H., Ohsugi, Y., Matsuda, T., Yawata, H., Hirano, T., Taga, T., and Kishimoto, T. 1990. Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. J. Biochem. 108: 673–676.
Vollmer, P., Peters, M., Ehlers, M., Yagame, H., Matsuba, T., Kondo, M., Yasukawa, K. Meyer zum Büschenfelde, K.H., and Rose-John, S., 1996. Yeast Expression of the Cytokine Receptor Domain of the Soluble Interleukin-6-Receptor. J. Immunol. Meth., 199: 47–54.
Brakenhoff, J.P.J., Hart, M., de Groot, E.R., Di Padova, F., and Aarden, L.A., 1990. Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxy-terminal deletion mutants. J. Immunol. 145: 561–568.
Gearing, D.P., Ziegler, S.F., Comeau, M.R., Friend, D., Thoma, B., Cosman, D., Park, L., and Mosley, B. 1994. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. Proc. Natl. Acad. Sci. USA 91: 1119–1123.
Tajima, S., Tsuji, K., Ebihara, Y., Sui, X., Tanaka, R., Muraoka, K., Yoshida, M., Yamada, K., Yasukawa, K., Taga, T., Kishimoto, T., and Nakahata, T. 1996. Analysis of Interleukin-6 Receptor and gp 130 Expressions and Proliferative Capability of Human CD34+ Cells. J. Exp. Med. 184: 1357–1364.
Ishibashi, T., Kimura, H., Shikama, Y., Uchida, T., Kariyone, S., Hirano, T., Kishimoto, T., Takatsuki, F., Akiyama, Y. 1989. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74: 1241–1244.
Porgador, A., Tzehoval, E., Katz, A., Vadai, E., Revel, M., Feldman, M. and Eisenbach, L. 1992. Interleukin-6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res 52: 3679–3686.
Treanor, J.J.S., Goodman, L., de Sauvage, F., Stone, D.M., Poulsen, K.T., Beck, C.D., Gray, C., Armanini, M.P., Pollock, R.A., Hefti, F., Phillips, H.S., Goddard, A., Moore, M.W., Buj-Bello, A., Davies, A.M., Asai, N., Takahashi, M., Vandlen, R., Henderson, C.E., and Rosenthal, A. 1996. Characterization of a multicomponent receptor for GDNF. Nature 382: 80–83.
Krüttgen, A., Rose-John, S., Möller, C., Wroblowski, B., Wollmer, A., Müllberg, J., Hirano, T., Kishimoto, T., and Heinrich, P.C. 1990. Structure-function analysis of human interleukin-6. Evidence for the involvement of the carboxy-terminus in function. FEBS Lett. 262: 323–326.
Oppmann, B., Stoyan, T., Vollmer, P., Voltz, N., Fischer, M., and Rose-John, S. 1996. A convenient assay for different species of cytokines and soluble receptors of the IL-6 type cytokine family. J. Immunol. Meth. 195: 153–159.
Van Dam, M., Müllberg, J., Schooltink, H., Stoyan, T., Brakenhoff, J., Heinrich, P.C., and Rose-John, S. 1993. Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules: involvement of two separate domains in receptor binding. J. Biol. Chem. 268: 15285–15290.
Ehlers, M., Grötzinger, A., De Hon, F.D., Brakenhoff, J.P.J., Liu, J., Wollmer, A., and Rose-John, S. 1994. Identification of two novel regions of Interleukin-6 involved in receptor binding and signal transduction. J. Immunol. 153: 1755–1764.
Keller, U., Aman, M.J., Derigs, G., Huber, C., Peschel, C. 1994. Human interleukin-4 enhances stromal cell-dependent hematopoiesis: costimulation with stem cell factor. Blood 84: 2189–2196.
Carson, M. 1991. Ribbons 2.0. J. Appl. Cryst. 24: 946–950.
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S., Nakajima, K., Koyoma, K., Iwamatu, A., Tsunasawa, S., Sakiyama, F., Matsui, H., Takahara, Y., Taniguchi, T. and Kishimoto, T. 1986. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324: 73–76.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fischer, M., Goldschmitt, J., Peschel, C. et al. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol 15, 142–145 (1997). https://doi.org/10.1038/nbt0297-142
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0297-142
This article is cited by
-
The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130
Molecular Neurodegeneration (2023)
-
The interleukin-11 receptor variant p.W307R results in craniosynostosis in humans
Scientific Reports (2023)
-
Human brain organoid model of maternal immune activation identifies radial glia cells as selectively vulnerable
Molecular Psychiatry (2023)
-
Targeting IL-6 trans-signalling: past, present and future prospects
Nature Reviews Immunology (2023)
-
Cytokimera GIL-11 rescued IL-6R deficient mice from partial hepatectomy-induced death by signaling via non-natural gp130:LIFR:IL-11R complexes
Communications Biology (2023)